Following our $2.7 million pre-seed announcement co-led by Speciale Invest and South Park Commons, with participation from Operators Studio, national business press, biotech trade publications, and our investors covered how Venomics AI is combining evolutionary venomics, multi-omics, and generative AI to turn animal venoms into novel therapeutics.
The IISc spinout will use the pre-seed funding to expand its Venom Atlas molecular database, strengthen AI-led drug discovery and laboratory screening, and validate potential drugs across hard-to-druggable human targets.
Read Business Standard ↗
The Economic Times covers how Venomics AI is combining evolutionary venom biology, multi-omics profiling, AI-driven design, and wet-lab validation to unlock novel peptide therapeutics.
Read The Economic Times ↗
Entrepreneur India highlights the co-founding team of Prof. Kartik Sunagar and Dr. Vinay Prabhu and how the pre-seed round co-led by Speciale Invest and South Park Commons accelerates platform scale-up.
Read Entrepreneur India ↗
International tech press coverage of IISc Bengaluru spin-out Venomics AI raising $2.7M to build out its Venom Atlas and translate unexplored animal toxins into targeted therapeutics.
Read Tech in Asia ↗
Inc42 explores how Venomics AI is mining the >99% of venomous species that remain molecularly uncharacterized to engineer precision therapeutics for ion channels, GPCRs, and metabolic targets.
Read Inc42 ↗
Reporting on Venomics AI's $2.7M pre-seed round co-led by Speciale Invest and South Park Commons, with participation from Operators Studio, to scale the Venom Atlas and AI-driven peptide therapeutic discovery.
Read Entrackr ↗
VCCircle's deep-tech deal roundup highlights Venomics AI's $2.7M pre-seed round co-led by Speciale Invest and South Park Commons to advance venom-derived therapeutic discovery.
Read VCCircle ↗
Businessworld's BW Disrupt covers the pre-seed investment backing Venomics AI's integrated multi-omics, generative AI, and wet-lab pharmacology platform at IISc Bengaluru.
Read BW Disrupt ↗
Trade coverage of IISc spinout Venomics AI raising $2.7M to integrate evolutionary venom biology, multi-omics sequencing, AI-guided structure modeling, and wet-lab functional validation.
Read BioSpectrum India ↗
How IISc spin-out Venomics AI is building a proprietary Venom Atlas and AI-first drug discovery engine to translate millions of years of natural toxin evolution into precision medicines.
Read Indian Startup News ↗
CIOL examines how Venomics AI combines deep-learning protein design with high-throughput venom transcriptomics and proteomics to compress early-stage drug discovery timelines.
Read CIOL ↗
Enterprise AI coverage highlighting how Venomics AI applies generative AI models to evolutionary toxin scaffolds to design highly selective therapeutic candidates.
Read Elets CIO ↗
Coverage of Venomics AI's US$2.7M pre-seed announcement and its mission to systematically map unexplored animal venoms and validate drug candidates in the laboratory.
Read CXOtoday ↗
Sector report on how Venomics AI bridges academic evolutionary venomics at IISc with industrial-scale AI drug discovery backed by Speciale Invest, South Park Commons, and Operators Studio.
Read SMEStreet ↗
Startup ecosystem coverage of IISc Bengaluru spin-out Venomics AI and its $2.7M pre-seed round to expand the Venom Atlas and accelerate preclinical therapeutic programs.
Read Bharat Fast ↗
Investment thesis from co-lead investor Speciale Invest on backing Prof. Kartik Sunagar and Dr. Vinay Prabhu to unlock the therapeutic potential of unexplored animal venoms with generative AI and high-throughput wet-lab biology.
Read Speciale Invest ↗
Syndicated feature on MSN India detailing how IISc-incubated Venomics AI is building an integrated wet-lab and computational discovery engine to turn animal toxins into life-saving medicines.
Read on MSN ↗
Global venture intelligence brief indexing Venomics AI's $2.7M pre-seed financing co-led by Speciale Invest and South Park Commons, with participation from Operators Studio.
View on Dealroom ↗